Targeting integrated stress response regulates microglial M1/M2 polarization and attenuates neuroinflammation following surgical brain injury in rat

Teng-Chao Huang,Lun Luo,Shi-Hai Jiang,Chuan Chen,Hai-Yong He,Chao-Feng Liang,Wen-Sheng Li,Hui Wang,Lei Zhu,Kun Wang,Ying Guo,Teng-chao Huang,Shi-hai Jiang,Hai-yong He,Chao-feng Liang,Wen-sheng Li
DOI: https://doi.org/10.1016/j.cellsig.2021.110048
IF: 4.85
2021-09-01
Cellular Signalling
Abstract:<p>Integrated stress response (ISR) contributes to various neuropathological processes and acting as a therapy target in CNS injuries. However, the fundamental role of ISR in regulating microglial polarization remains largely unknown. Currently no proper pharmacological approaches to reverse microglia-driven neuroinflammation in surgical brain injury (SBI) have been reported. Here we found that inhibition of the crucial ISR effector, activating transcription factor 4 (ATF4), using the RNA interference suppressed the lipopolysaccharide (LPS)-stimulated microglial M1 polarization <em>in vitro</em>. Interestingly, counteracting ISR with a small-molecule ISR inhibitor (ISRIB) resulted in a significant microglial M1 towards M2 phenotype switching after LPS treatment. The potential underlying mechanisms may related to downregulate the intracellular NADPH oxidase 4 (NOX4) expression under the neuroinflammatory microenvironment. Notably, ISRIB ameliorated the infiltration of microglia and improved the neurobehavioral outcomes in the SBI rat model. Overall, our findings suggest that targeting ISR exerts a novel anti-inflammatory effect on microglia via regulating M1/M2 phenotype and may represent a potential therapeutic target to overcome neuroinflammation following SBI.</p>
cell biology
What problem does this paper attempt to address?